| Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012 PJ Turner, MH Gowland, V Sharma, D Ierodiakonou, N Harper, T Garcez, ... Journal of Allergy and Clinical Immunology 135 (4), 956-963. e1, 2015 | 721 | 2015 |
| Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. R Gupta, VP Gupta, M Sarna, S Bhatnagar, J Thanvi, V Sharma, AK Singh, ... Indian heart journal 54 (1), 59-66, 2002 | 461 | 2002 |
| Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids BR Haugen, LL Larson, U Pugazhenthi, WR Hays, JP Klopper, ... The Journal of Clinical Endocrinology & Metabolism 89 (1), 272-280, 2004 | 143 | 2004 |
| Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey D Chopra, H Rehan, V Sharma, R Mishra Indian Journal of Medical and Paediatric Oncology 37 (01), 42-46, 2016 | 132 | 2016 |
| Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial JOB Hourihane, K Beyer, A Abbas, M Fernández-Rivas, PJ Turner, ... The Lancet Child & Adolescent Health 4 (10), 728-739, 2020 | 126 | 2020 |
| Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis CM Chan, X Jing, LA Pike, Q Zhou, DJ Lim, SB Sams, GS Lund, V Sharma, ... Clinical Cancer Research 18 (13), 3580-3591, 2012 | 115 | 2012 |
| Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer JA Morrison, LA Pike, SB Sams, V Sharma, Q Zhou, JJ Severson, AC Tan, ... Molecular cancer 13, 1-13, 2014 | 108 | 2014 |
| Management of ocular allergy A Leonardi, D Silva, D Perez Formigo, B Bozkurt, V Sharma, P Allegri, ... Allergy 74 (9), 1611-1630, 2019 | 95 | 2019 |
| Continuous and daily oral immunotherapy for peanut allergy: results from a 2-year open-label follow-on study BP Vickery, A Vereda, C Nilsson, G du Toit, WG Shreffler, AW Burks, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (5), 1879-1889 …, 2021 | 68 | 2021 |
| Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy M Fernandez‐Rivas, A Vereda, BP Vickery, V Sharma, C Nilsson, ... Allergy 77 (3), 991-1003, 2022 | 42 | 2022 |
